TY - CHAP A1 - Vivek Kaushik A2 - Juan Sebastian Yakisich A3 - Yogesh Kulkarni A4 - Neelam Azad A5 - Anand Krishnan V. Iyer ED1 - Alba Fabiola Costa Torres Y1 - 2018-10-31 PY - 2018 T1 - Chemoresistance of Lung Cancer Cells: 2D and 3D In Vitro Models for Anticancer Drug Screening N2 - Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors, and mechanisms involved in initiation and tumor progression, important improvements have occurred in diagnostics and therapeutics in the shape of advances in molecular genotyping, procedures for sampling, new potential, and less invasive sources of samples for the diagnosis and development of new targeted therapies. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer. BT - Lung Cancer SP - Ch. 9 UR - https://doi.org/10.5772/intechopen.78946 DO - 10.5772/intechopen.78946 SN - 978-1-78984-350-7 PB - IntechOpen CY - Rijeka Y2 - 2020-08-12 ER -